1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1:

Previous fractures

Cortoss (n = 162)PMMA (n = 94)Total (n = 256)
No. of patients with any previous fracturesa56 (34.6%)31 (33.0%)87 (34.0%)
Total no. of levels with previous fracturesb10660166
No. of patients with any previous fractures (treated)c20 (12.3%)13 (13.8%)33 (12.9%)
Total no. of levels with previous fractures (treated)332558
No. of patients with any previous fractures (untreated)d39 (24.1%)21 (22.3%)60 (23.4%)
Total no. of levels with previous fractures (untreated)e7335108
  • a Excludes pre-existing untreated fractures that were treated along with the acute fracture in the current study. Includes treated and untreated fractures other than the index treated levels.

  • b Includes all levels with previously treated fractures and all levels with previous untreated fractures, excluding those levels treated in the current study.

  • c No. and percentage of patients with any previous fractures treated with vertebral augmentation.

  • d Excludes untreated levels treated in the current study.

  • e Excludes levels treated in the current study.